Fredun Pharmaceuticals Limited has provided prior intimation of its upcoming Board of Directors meeting scheduled for Thursday, 05th November, 2026. The meeting will be conducted pursuant to Regulation 29 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The primary agenda items for the board meeting include:
- Discussion, consideration, and approval of Unaudited Standalone Financial Results for the Quarter and Half Year ended September 30, 2026
- Discussion, consideration, and approval of Unaudited Consolidated Financial Results for the Quarter and Half Year ended September 30, 2026
- Any other matter with the permission of the Chair
The company also disclosed that the trading window for dealing in the company's securities has been closed since October 01, 2026, in continuation of the intimation dated September 28, 2026. This closure is pursuant to the company's "Code of Conduct" formed under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and amendments thereunder.
The trading window will remain closed until forty-eight hours after the declaration of financial results for the Quarter and Half Year ended September 30, 2026. This restriction has been communicated to Directors, Key Managerial Personnel, Employees of the Company, and their immediate relatives.